Insight & Intelligence

More »

New Products

More »
August 1, 2017 (Vol. 37 , No. 14)

Monoclonal Antibodies

Click Image To Enlarge +

The Binding Site

The Binding Site has recently introduced new mAbs focused on infectious diseases, including CMV, hepatitis (A, B, C, and D), herpes, HIV, rubella, and toxoplasmosis. Availability of these products will enhance the needs of biopharmaceutical, clinical, and life-science researchers, along with in vitro diagnostic manufacturers. All of these antibodies exhibit outstanding degrees of specificity, while demonstrating high levels of purity, extended shelf-life stability, and lot-to-lot consistencies. The infectious disease mAbs are all available in a standard-sized 1.0-mg fill format, while the rest come in a 0.2-mg fill format. Bulk packaging and customer-specific packaging options are available as well.

Related To This Company